Loading clinical trials...
Loading clinical trials...
Immunogenicity, Safety, and Tolerability of a Plant-Derived Seasonal Virus-Like-Particle Quadrivalent Influenza Vaccine in Adults
Conditions
Interventions
Low dose of quadrivalent VLP vaccine
Medium dose of quadrivalent VLP vaccine
+2 more
Locations
2
United States
Broward Research Group
Hollywood, Florida, United States
Miami Research Associates
Miami, Florida, United States
Start Date
July 28, 2014
Primary Completion Date
June 22, 2015
Completion Date
June 22, 2015
Last Updated
November 13, 2019
NCT05907564
NCT04657120
NCT04170348
NCT05622942
NCT05592431
NCT06113757
Lead Sponsor
Medicago
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions